Dey, L.P. Company Profile

07:49 EDT 22nd August 2014 | BioPortfolio

Dey, L.P., a subsidiary of Mylan Inc. (NYSE: MYL), is a specialty pharmaceutical company focused on the development, manufacturing and marketing of prescription drug products for the treatment of respiratory diseases, respiratory-related allergies, and emergency care medicine. As the U.S. leader in sales of nebulized respiratory medication, Dey, L.P. puts patients first through its development of innovative and affordable therapies. The Web sites for Dey, L.P. include www.dey.com, www.curosurfusa.com, www.epipen.com and www.perforomist.com.


News Articles [631862 Results]

Hana Biologics & Somatix merge as Somatix Therapy Corp.

Hana Biologics and Somatix combined their complementary technologies by merging into a new company named Somatix Therapy Corp., based in Alamada, CA. The stock-swap transaction is valued at approxima...

Sepracor acquires IBF Biotech from Rhone-Poulenc

Sepracor has acquired IBF Biotechnics SA (biopharmaceutical purification products) from Rhone-Poulenc SA for $19.1 million consisting of a combination of cash, notes payable, warrants, and equity secu...

Genex Corp. sells Protein G business to Pharmacia LKB Biotech

Genex Corporation (specialty pharmaceuticals) sold its Protein G business, used in affinity chromatography, to Pharmacia LKB Biotechnology for approximately $2 million.

Eli Lilly profits $7.6M from divesting 5% share of Synergen

Eli Lilly divested its 5% share in Synergen, selling 537,900 shares at $271/8 for gross proceeds of $14.6 million and a profit of $7.6 million.

Incyte buys Invitron assets

Incyte Pharmaceuticals acquired the technology developed at Invitron's Redwood City, California laboratories, including technology developed by Invitron's Ideon subsidiary, for $1,225,000.

Applied bioTech. acquires Du Pont's share of Oncogenetic

Applied bioTechnology (developing genetically-engineered products for the diagnosis and treatment of cancer) acquired Du Pont's 50% share of Oncogenetic Partners, their joint venture formed in 1986 to...

Abbott Labs sells last 2.5 million share stake in Amgen

Abbott Laboratories has sold its remaining 2.5 million share stake in Amgen on the open market, reportedly on February 6 in a single transaction at $82 1/2 per share.

Genta acquires JBL Scientific to get own biochemical source

Genta (developing pharmaceuticals based on antisense oligonucleotide technology) has acquired JBL Scientific, a supplier of specialty biochemicals to the pharmaceutical and diagnostic industries.

Clinical Trials [66380 Results]

The Utility of Peri-operative Arnica Montana for Reduction of Ecchymosis in Rhinoplasty Surgery

Arnica montana is a homeopathic drug that is made in accordance with the official methods of the Homeopathic Pharmacopoeia of the United States (HPUS) and is commonly used by cosmetic surg...

Pharyngeal Size in Patients With Obstructive Tonsils Under Orthodontic Treatment

Enlarged tonsils and malocclusion has relationship with sleep disturbance in children. The consequences of these features can include aggravation of craniofacial growth such that the devel...

The Biology of Chronic Preconditioning: Genomic and Physiologic Mechanisms of Response

The purpose of this study is to assess the effects of repeated RIPC and exercise, on exercise performance, skeletal muscle responses and circulating cellular and humoral biology in humans

Pilot Study of Raltegravir Lipodystrophy IISP

The substitution of raltegravir for the NRTIs will result in some reversal of the long term adverse effect of lipodystrophy (specifically peripheral lipoatrophy) that is associated with th...

Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or Chemotherapy

Brief Summary: RATIONALE: Comparing results of diagnostic procedures, such as esophagoscopy, done before and after radiation therapy and/or chemotherapy may help doctors predict a patient...

Companies [46926 Results]

Biogen Idec Inc.

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufa...

OurPaths

Compugen Ltd.

Compugen is a leading drug and diagnostic product candidate discovery company. Unlike traditional high throughput trial and error experimental based discovery, Compugen's discovery efforts are b...

Schiff Nutrition International, Inc.

Schiff Nutrition International, Inc. develops, manufactures, markets and distributes branded and private label vitamins, nutritional supplements and nutrition bars in the United S...

Fero Industries, Inc.

Fero Industries, Inc. is a publicly traded holding company (OTC BB: FROI.OB). Fero’s mission is to acquire healthcare related companies, products, and technologies that have large market poten...

More Information about "Dey, L.P." on BioPortfolio

We have published hundreds of Dey, L.P. news stories on BioPortfolio along with dozens of Dey, L.P. Clinical Trials and PubMed Articles about Dey, L.P. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dey, L.P. Companies in our database. You can also find out about relevant Dey, L.P. Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Relevant Topic

Allergies
Latest News Clinical Trials Research Drugs Reports Corporate
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...

Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record